Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: TNYA) | Delayed: 0.38 -0.01 (2.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.39 | 52 Week High | $ | |||
| Open | $0.39 | 52 Week Low | $ | |||
| Day High | $0.40 | P/E | N/A | |||
| Day Low | $0.38 | EPS | $ | |||
| Volume | 562,517 | |||||
